Interaction of d-tubocurarine with potassium channels: Molecular modeling and ligand binding

Molecular Pharmacology

Volumn 69, Issue 4, 2006, Pages 1356-1365

  Rossokhin, Alexei ^a   Teodorescu, Georgeta ^b   Grissmer, Stephan ^b   Zhorov, Boris S ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUBOCURARINE CHLORIDE; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CRYSTAL STRUCTURE; ENERGY TRANSFER; LIGAND BINDING; MOLECULAR MODEL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; CELL LINE; KV1.3 POTASSIUM CHANNEL; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; TUBOCURARINE; X-RAY DIFFRACTION;

EID: 33645104604     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.017970     Document Type: Article

References (46)

1. 2+- dependent non-selective cation and potassium channels activated by bradykinin in pig coronary artery endothelial cells. J Physiol (Lond) 493:691-706.
2. Berneche S and Roux B (2005) A gate in the selectivity filter of potassium channels. Structure 13:591-600.
3. Birnbaum SG, Varga AW, Yuan LL, Anderson AE, Sweatt JD, and Schrader LA (2004) Structure and function of Kv4-family transient potassium channels. Physiol Rev 84:803-833.
4. Brelidze TI, Niu X, and Magleby KL (2003) A ring of eight conserved negatively charged amino acids doubles the conductance of BK channels and prevents inward rectification. Proc Natl Acad Sci USA 100:9017-9022.
5. Brooks CL, Pettitt BM, and Karplus M (1985) Structural and energetic effects of truncating long ranged interactions in ionic polar fluids. J Chem Phys 83:5897-5908.
6. Bruhova I and Zhorov BS (2005) KvAP-based model of the pore region of Shaker potassium channel is consistent with cadmium- and ligand-binding experiments. Biophys J 89:1020-1029.
7. + channels as targets for specific immunomodulation. Trends Pharmacol Sci 25:280-289.
8. Codding PW and James MNG (1973) The crystal and molecular structure of a potent neuromuscular blocking agent: d-tubocurarine dichloride pentahydrate. Acta Crystallogr B 29:935-942.
9. + channels. J Biol Chem 279:394-400.
10. Dewar MJS, Zoebisch EG, Healy EF, and Stewart JJP (1985) AM1: a new general purpose quantum mechanical molecular model. J Am Chem Soc 107:3902-3909.
11. + conduction and selectivity. Science (Wash DC) 280:69-77.
12. Egan TM, Dagan D, and Levitan IB (1993) Properties and modulation of a calcium-activated potassium channel in rat olfactory bulb neurons. J Neurophysiol 69:1433-1442.
13. Felix JP, King VF, Shevell JL, Garcia ML, Kaczorowski GJ, Bick IR, and Slaughter RS (1992) Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site. Biochemistry 31:11793-11800.
14. Go N and Scheraga HA (1970) Ring closure and local conformational deformations of chain molecules. Macromolecules 3:178-187.
15. + channels, types Kv1.1, 1.2, 1.3, 1.5 and 3.1, stably expressed in mammalian cell lines. Mol Pharmacol 45:1227-1234.
16. Hamill OP, Marty A, Neher E, Sakmann B, and Sigworth FJ (1981) Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflueg Arch Eur J Physiol 391:85-100.
17. Hanner M, Green B, Gao YD, Schmalhofer WA, Matyskiela M, Durand DJ, Felix JP, Linde AR, Bordallo C, Kaczorowski GJ, et al. (2001) Binding of correolide to the K(v)1.3 potassium channel: characterization of the binding domain by site-directed mutagenesis. Biochemistry 40:11687-11697.
18. Hanner M, Schmalhofer WA, Green B, Bordallo C, Liu J, Slaughter RS, Kaczorowski GJ, and Garcia ML (1999) Binding of correolide to K(v)1 family potassium channels. Mapping the domains of high affinity interaction. J Biol Chem 274:25237-25244.
19. Hille B (2001) Ionic Channels of Excitable Membrane, Sinauer Associates, Inc., Sunderland, MA.
20. Jiang Y, Lee A, Chen J, Cadene M, Chait BT, and MacKinnon R (2002) Crystal structure and mechanism of a calcium-gated potassium channel. Nature (Lond) 417:515-522.
21. + channel. Nature (Lond) 423:33-41.
22. Kuo A, Gulbis JM, Antcliff JF, Rahman T, Lowe ED, Zimmer J, Cuthbertson J, Ashcroft FM, Ezaki T, and Doyle DA (2003) Crystal structure of the potassium channel KirBac1.1 in the closed state. Science (Wash DC) 300:1922-1926.
23. Lazaridis T and Karplus M (1999) Effective energy function for proteins in solution. Proteins Struct Funct Genet 35:133-152.
24. Lenaeus MJ, Vamvouka M, Focia PJ, and Gross A (2005) Structural basis of TEA blockade in a model potassium channel. Nat Struct Mol Biol 12:454-459.
25. Li Z and Scheraga HA (1987) Monte Carlo-minimization approach to the multiple-minima problem in protein folding. Proc Natl Acad Sci USA 84:6611-6615.
26. + channel. Science (Wash DC) 309:897-903.
27. Long SB, Campbell EB, and Mackinnon R (2005b) Voltage sensor of Kv1.2: structural basis of electromechanical coupling. Science (Wash DC) 309:903-908.
28. Mathie A, Wooltorton JR, and Watkins CS (1998) Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. Gen Pharmacol 30:13-24.
29. Mitcheson JS, Chen J, Lin M, Culberson C, and Sanguinetti MC (2000) A structural basis for drug-induced long QT syndrome. Proc Natl Acad Sci USA 97:12329-12333.
30. Nimigean CM, Chappie JS, and Miller C (2003) Electrostatic tuning of ion conductance in potassium channels. Biochemistry 42:9263-9268.
31. Rauer H and Grissmer S (1996) Evidence for an internal phenylalkylamine action on the voltage-gated potassium channel Kv1.3. Mol Pharmacol 50:1625-1634.
32. Reynolds CD and Palmer RA (1976) The crystal structure, absolute configuration and stereochemistry of (+)-tubocurarine dibromide methanol solvate: a potent neuromuscular blocking agent. Acta Crystallogr B 32:1431-1439.
33. Seebohm G, Chen J, Strutz N, Culberson C, Lerche C, and Sanguinetti MC (2003) Molecular determinants of KCNQ1 channel block by a benzodiazepine. Mol Pharmacol 64:70-77.
34. Tamargo J, Caballero R, Gomez R, Valenzuela C, and Delpon E (2004) Pharmacology of cardiac potassium channels. Cardiovasc Res 62:9-33.
35. Tikhonov DB and Zhorov BS (1998) Kinked-helices model of the nicotinic acetylcholine receptor ion channel and its complexes with blockers: simulation by the Monte Carlo minimization method. Biophys J 74:242-255.
36. Tikhonov DB and Zhorov BS (2005) Modeling p-loops domain of sodium channel: homology with potassium channels and interaction with ligands. Biophys J 88:1-14.
37. + channels defined by high-affinity metal bridges. Nature (Lond) 428:864-868.
38. Weiner J, Kollman PA, Case DA, Singh UC, Chio C, Alagona G, Profeta S, and Weiner PK (1984) A new force field for molecular mechanical simulation of nucleic acids and proteins. J Am Chem Soc 106:765-784.
39. + completely comfortable. Nat Struct Biol 8:1011-1013.
40. Zhorov BS and Brovtsyna NB (1993) Conformational analysis of d-tubocurarine: implications for minimal dimensions of its binding site within ion channels. J Membr Biol 135:19-26.
41. Zhorov BS, Brovtsyna NB, Gmiro VE, Lukomskaya N, Serdyuk SE, Potapyeva NN, Magazanik LG, Kurenniy DE, and Skok VI (1991) Dimensions of the ion channel in neuronal nicotinic acetylcholine receptor as estimated from analysis of conformation-activity relationships of open-channel blocking drugs. J Membr Biol 121:119-132.
42. Zhorov BS and Tikhonov DB (2004) Potassium, sodium, calcium and glutamate-gated channels: pore architecture and ligand action. J Neurochem 88:782-799.
43. Zhou X-B, Schlossmann J, Hofmann F, Ruth P, and Korth M (1998) Regulation of stably expressed and native BK channels from human myometrium by cGMP- and cAMP-dependent protein kinase. Pflueg Arch Eur J Physiol 436:725-734.
44. + selectivity filter: charge balance and coupling of ion binding to a protein conformational changes underlie high conduction rate. J Mol Biol 333:965-975.
45. + channel-Fab complex at 2 A resolution. Nature (Lond) 414:43-48.
46. Zhou Y, Morais Cabral JH, Mann S, and MacKinnon R (2001a) Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors. Nature (Lond) 411:657-661.